Cell proliferation at the leading invasive front of colonic carcinomas. Preliminary observations

Anticancer Research

Volumn 26, Issue 3 B, 2006, Pages 2275-2278

  Rubio, C A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Carcinoma; Colon; Invasion; Proliferation

Indexed keywords

KI 67 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR CELL;

ADENOCARCINOMA; CELL GROWTH PROCESSES; COLONIC NEOPLASMS; HUMANS; KI-67 ANTIGEN; NEOPLASM INVASIVENESS;

EID: 33745571569     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Newland R, Dent R, Lyttle N, Chapuis P and Bokey E: Pathological determinants of survival associated with colorectal cancer. Cancer 73: 2076-2082, 1993.
2. Hase K, Shatney C, Johnson D, Trollope M and Vierra M: Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum 36: 627-635, 1993.
3. Mac Carry WG: Principles of prognosis in cancer. JAMA 96: 30-33, 1931.
4. Wells A: Tumor invasion: role of growth factor-induced cell motility. In: Advances in Cancer Research. Vol 78, Vande Woude G and Klein G (eds.). Academic Press, San Diego, pp. 31-99, 2000.
5. Friedl P and Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. Review 3: 362-374, 2003.
6. Choi H, Jung I, Kim S and Hong S: Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas Dis Colon Rectum 40: 51-59, 1997.
7. Yang JL, Ow KT, Russell PJ, Ham JM and Crowe PJ: Higher expression of oncoproteins c-myc, c-erb B-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors. Ann Surg Oncol 3: 574-579, 1996.
8. Cristi E, Perrone G, Toscano G, Verzi A, Nori S, Santini D, Tonini G, Vetrani A, Fabiano A and Rabitti C: Tumour proliferation, angiogenesis, and ploidy status in human colon cancer. J Clin Pathol 58: 1170-1174, 2005.
9. Kanamaru T, Tanaka K, Kotani J, Ueno K, Yamamoto M, Idei Y, Hisatomi H and Takeyama Y: Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer. Int J Mol Med 10: 205-210, 2002.
10. Malhotra S, Newman E, Eisenberg D, Scholes J, Wieczorek R, Mignatti P and Shamamian P: Increased membrane type 1 matrix metalloproteinase expression from adenoma to colon cancer: a possible mechanism of neoplastic progression. Dis Colon Rectum 45: 537-543, 2002.
11. Rubio CA: Colorectal carcinomas. Possible mechanism of local tumor progression. Anticancer Res 23: 347-350, 2003.
12. Rubio CA: Further studies on the histological characteristics linked to local tumour invasion in colorectal carcinomas. Anticancer Res 23: 3555-3560, 2003.
13. Rubio CA and Lindhblom A: Histological changes pertinent to local tumor progression. In: Hereditary Nonpolyposis Colorectal Cancer (HNPCC). Anticancer Res 24: 1765-1768, 2004.
14. Rubio CA: Adenocarcinoma in inflammatory colorectal disease. Histologic features pertinent to local tumour progression. Anticancer Res 23: 4313-4318, 2003.
15. Rubio CA: Possible mechanism of local tumor progression in experimentally-induced colorectal carcinomas in rats. In Vivo 77: 97-100, 2003.
16. Rubio CA: Possible mechanism connected with the progression of submucosal invasion in colorectal neoplasias, Anticancer Res 25: 2503-2508, 2005.
17. Rubio CA: Colorectal cancer. A tumour with open borders. Adv Clin Exper Med 14: 863-867, 2005.
18. Rubio CA and Lagergren J: Histological features pertinent to local tumour progression in Barrett's adenocarcinoma. Anticancer Res 23: 3015-3018, 2003.
19. Rubio CA: Colorectal adenomatous cells produce lysozyme. Anticancer Res 23: 5165-5172, 2003.
20. Hazen LG, Bleeker FE, Lauritzen B, Bahns S, Song J, Jonker A, Van Driel BE, Lyon H, Hansen U, Kohler A and Van Noorden CJ: Comparative localization of cathepsin B protein and activity in colorectal cancer. J Histochem Cytochem 48: 1421-1430, 2000.
21. Joyce JA, Baruch A, Chehade K, Meyer-Morse N, Giraudo E, Tsai FY, Greenbaum DC, Hager JH, Bogyo M and Hanahan D: Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5: 443-453, 2004.
22. Turk V, Kos J and Turk B: Cysteine cathepsins (proteases) On the main stage of cancer? Cancer Cell 5: 409-410, 2004.
23. Kopito RR and Sitia R: Aggresomes and Russell bodies. Symptoms of cellular indigestion? Review EMBO Rep 1: 225-31, 2000.
24. Kroemer G and Jäätela M: Lysosomes and autophagy in cell death control. Nature Rev/Cancer 5: 886-897, 2005.
25. Chen R, Yi EC, Donohoe S, Pan S, Eng J, Cooke K, Crispin DA, Lane Z, Goodlett DR, Bronner MP, Aebersold R and Brentall TA: Pancreatic cancer proteome: the proteins that underlie invasion, metastasis and immunologic escape. Gastroenterology 729: 1187-1197, 2005.
26. Rubio CA, Kumagai J, Kanamori T and Nakamura K: Apoptosis in flat neoplasias of the colorectal mucosa. In Vivo 9: 606-609, 1995.